Bisamide CXCR4 Modulators: Novel Anti‐IBD Agents Acting on the Chemotaxis of Inflammatory Cells-Reference-Cited by-同舟云学术

Bisamide CXCR4 Modulators: Novel Anti‐IBD Agents Acting on the Chemotaxis of Inflammatory Cells

Published:2022-04-27 Issue:6 Volume:5 Page:2100223
ISSN:2366-3987
Container-title:Advanced Therapeutics
language:en
Short-container-title:Advanced Therapeutics

Author:

Bai Renren¹²^ORCID,Jiang Xiaoying³,Hui Zi¹²,Yoon Younghyoun⁴,Ge Jiamin¹²,Zhu Junlong¹²,Shim Hyunsuk⁴⁵

Affiliation:

1. School of Pharmacy Hangzhou Normal University Hangzhou Zhejiang 311121 P. R. China

2. Key Laboratory of Elemene Class Anti‐Cancer Chinese Medicine of Zhejiang Province Engineering Laboratory of Development and Application of Traditional Chinese Medicine from Zhejiang Province Collaborative Innovation Center of Chinese Medicines from Zhejiang Province Hangzhou Normal University Hangzhou 311121 P. R. China

3. College of Material, Chemistry and Chemical Engineering, Key Laboratory of Organosilicon Chemistry and Material Technology, Ministry of Education Hangzhou Normal University Hangzhou 311121 P. R. China

4. Department of Radiation Oncology, School of Medicine Emory University Atlanta GA 30322 USA

5. Winship Cancer Institute Emory University Atlanta GA 30322 USA

Funder

Natural Science Foundation of Zhejiang Province

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pharmacology (medical),Biochemistry (medical),Genetics (clinical),Pharmaceutical Science,Pharmacology,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adtp.202100223

Reference21 articles.